BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 24937636)

  • 1. Development of a multiplex methylation specific PCR suitable for (early) detection of non-small cell lung cancer.
    Nawaz I; Qiu X; Wu H; Li Y; Fan Y; Hu LF; Zhou Q; Ernberg I
    Epigenetics; 2014 Aug; 9(8):1138-48. PubMed ID: 24937636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methylation of multiple genes as a candidate biomarker in non-small cell lung cancer.
    Zhang Y; Wang R; Song H; Huang G; Yi J; Zheng Y; Wang J; Chen L
    Cancer Lett; 2011 Apr; 303(1):21-8. PubMed ID: 21255913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative analysis of mRNA expression levels and DNA methylation profiles of three neighboring genes: FUS1, NPRL2/G21 and RASSF1A in non-small cell lung cancer patients.
    Pastuszak-Lewandoska D; Kordiak J; Migdalska-Sęk M; Czarnecka KH; Antczak A; Górski P; Nawrot E; Kiszałkiewicz JM; Domańska D; Brzeziańska-Lasota E
    Respir Res; 2015 Jun; 16(1):76. PubMed ID: 26112163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression level and methylation status of three tumor suppressor genes, DLEC1, ITGA9 and MLH1, in non-small cell lung cancer.
    Pastuszak-Lewandoska D; Kordiak J; Antczak A; Migdalska-Sęk M; Czarnecka KH; Górski P; Nawrot E; Kiszałkiewicz JM; Domańska-Senderowska D; Brzeziańska-Lasota E
    Med Oncol; 2016 Jul; 33(7):75. PubMed ID: 27287342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequent epigenetic inactivation of deleted in lung and esophageal cancer 1 gene by promoter methylation in non-small-cell lung cancer.
    Zhang Y; Miao Y; Yi J; Wang R; Chen L
    Clin Lung Cancer; 2010 Jul; 11(4):264-70. PubMed ID: 20630829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Panel of Novel Detection and Prognostic Methylated DNA Markers in Primary Non-Small Cell Lung Cancer and Serum DNA.
    Ooki A; Maleki Z; Tsay JJ; Goparaju C; Brait M; Turaga N; Nam HS; Rom WN; Pass HI; Sidransky D; Guerrero-Preston R; Hoque MO
    Clin Cancer Res; 2017 Nov; 23(22):7141-7152. PubMed ID: 28855354
    [No Abstract]   [Full Text] [Related]  

  • 7. Detection of nasopharyngeal carcinoma in Morocco (North Africa) using a multiplex methylation-specific PCR biomarker assay.
    Nawaz I; Moumad K; Martorelli D; Ennaji MM; Zhou X; Zhang Z; Dolcetti R; Khyatti M; Ernberg I; Hu LF
    Clin Epigenetics; 2015; 7(1):89. PubMed ID: 26300994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [DNA methylation of tumor suppressor genes located on chromosome 3p in non-small cell lung cancer].
    Song H; Yi J; Zhang Y; Wang R; Chen L
    Zhongguo Fei Ai Za Zhi; 2011 Mar; 14(3):233-8. PubMed ID: 21426665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CpG island methylator phenotype involving tumor suppressor genes located on chromosome 3p in non-small cell lung cancer.
    Liu Z; Zhao J; Chen XF; Li W; Liu R; Lei Z; Liu X; Peng X; Xu K; Chen J; Liu H; Zhou QH; Zhang HT
    Lung Cancer; 2008 Oct; 62(1):15-22. PubMed ID: 18358560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA methylation analysis of tumor suppressor genes in liquid biopsy components of early stage NSCLC: a promising tool for early detection.
    Markou Α; Londra D; Tserpeli V; Kollias Ι; Tsaroucha E; Vamvakaris I; Potaris K; Pateras I; Kotsakis Α; Georgoulias V; Lianidou Ε
    Clin Epigenetics; 2022 May; 14(1):61. PubMed ID: 35538556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a non-invasive method, multiplex methylation specific PCR (MMSP), for early diagnosis of nasopharyngeal carcinoma.
    Zhang Z; Sun D; Hutajulu SH; Nawaz I; Nguyen Van D; Huang G; Haryana SM; Middeldorp JM; Ernberg I; Hu LF
    PLoS One; 2012; 7(11):e45908. PubMed ID: 23144779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA methylation analysis of selected genes for the detection of early-stage lung cancer using circulating cell-free DNA.
    Yang Z; Qi W; Sun L; Zhou H; Zhou B; Hu Y
    Adv Clin Exp Med; 2019 Mar; 28(3):355-360. PubMed ID: 30516882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RASSF1A, APC, ESR1, ABCB1 and HOXC9, but not p16INK4A, DAPK1, PTEN and MT1G genes were frequently methylated in the stage I non-small cell lung cancer in China.
    Lin Q; Geng J; Ma K; Yu J; Sun J; Shen Z; Bao G; Chen Y; Zhang H; He Y; Luo X; Feng X; Zhu J
    J Cancer Res Clin Oncol; 2009 Dec; 135(12):1675-84. PubMed ID: 19506903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultrasensitive DNA hypermethylation detection using plasma for early detection of NSCLC: a study in Chinese patients with very small nodules.
    Chen C; Huang X; Yin W; Peng M; Wu F; Wu X; Tang J; Chen M; Wang X; Hulbert A; Brock MV; Liu W; Herman JG; Yu F
    Clin Epigenetics; 2020 Mar; 12(1):39. PubMed ID: 32138766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RASSF1A is not appropriate as an early detection marker or a prognostic marker for non-small cell lung cancer.
    Choi N; Son DS; Song I; Lee HS; Lim YS; Song MS; Lim DS; Lee J; Kim H; Kim J
    Int J Cancer; 2005 Jul; 115(4):575-81. PubMed ID: 15700308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant methylation in non-small cell lung cancer.
    Suzuki M; Yoshino I
    Surg Today; 2010 Jul; 40(7):602-7. PubMed ID: 20582509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome-wide combination profiling of DNA copy number and methylation for deciphering biomarkers in non-small cell lung cancer patients.
    Son JW; Jeong KJ; Jean WS; Park SY; Jheon S; Cho HM; Park CG; Lee HY; Kang J
    Cancer Lett; 2011 Dec; 311(1):29-37. PubMed ID: 21757291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A panel of promoter methylation markers for invasive and noninvasive early detection of NSCLC using a quantum dots-based FRET approach.
    Ma Y; Bai Y; Mao H; Hong Q; Yang D; Zhang H; Liu F; Wu Z; Jin Q; Zhou H; Cao J; Zhao J; Zhong X; Mao H
    Biosens Bioelectron; 2016 Nov; 85():641-648. PubMed ID: 27240011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant methylation of RASGRF2 and RASSF1A in human non-small cell lung cancer.
    Chen H; Suzuki M; Nakamura Y; Ohira M; Ando S; Iida T; Nakajima T; Nakagawara A; Kimura H
    Oncol Rep; 2006 May; 15(5):1281-5. PubMed ID: 16596198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potentialities of aberrantly methylated circulating DNA for diagnostics and post-treatment follow-up of lung cancer patients.
    Ponomaryova AA; Rykova EY; Cherdyntseva NV; Skvortsova TE; Dobrodeev AY; Zav'yalov AA; Bryzgalov LO; Tuzikov SA; Vlassov VV; Laktionov PP
    Lung Cancer; 2013 Sep; 81(3):397-403. PubMed ID: 23806794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.